Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants

AIDS

Volumn 30, Issue 3, 2016, Pages 525-527

  Liotta, Giuseppe ^a   Floridia, Marco ^b   Andreotti, Mauro ^b   Jere, Haswell ^c   Sagno, Jean Baptiste ^c   Marazzi, Maria C ^d   Buonomo, Ersilia ^a   Scarcella, Paola ^a   Mancinelli, Sandro ^a   Vella, Stefano ^b   Giuliano, Marina ^b   Palombi, Leonardo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c DREAM Program   (Malawi)

^d LUMSA UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; BREAST FEEDING; CHILD GROWTH; COHORT ANALYSIS; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALAWI; PERINATAL PERIOD; PRIORITY JOURNAL; VERTICAL TRANSMISSION; CHILD DEVELOPMENT; HIV INFECTIONS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

ANTI-HIV AGENTS; BREAST FEEDING; CHILD DEVELOPMENT; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALAWI; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TENOFOVIR;

EID: 84957882397     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000944     Document Type: Article

References (6)

1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: World Health Organization, 2013.
2. O'Brien L, Shaffer N, Sangrujee N, Abimbola TO. The incremental cost of switching from Option B to Option BR for the prevention of mother-to-child transmission of HIV. Bull World Health Organ 2014; 92:162-170.
3. Kim MH, Ahmed S, Hosseinipour MC, Giordano TP, Chiao EY, Yu X, et al. The impact of option BR on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2015; 68:77-83.
4. Siberry GK, Williams PL, Mendez H, Seage GR, Jacobson DL, Hazra R, et al. Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS 2012; 26:1151-1159.
5. Giuliano M, Andreotti M, Liotta G, Jere H, Sagno J-B, Maulidi M, et al. Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery. PLoS ONE 2013; 8:e68950.
6. WHOANTHRO, version 3.2.2, January 2011: Department of Nutrition, World Health Organization Avenue Appia 20, Geneva, Switzerland. http://who.int/childgrowth/en. [Accessed 8 July 2015]